Skip to NavigationSkip to content

News

0
Astrazeneca image
Profits slump at AstraZeneca
Q1 figures continue recent trend but firm remains bullish on prospects for growth
0
sovaldi iamge
Sovaldi performs for Gilead
High sales of newly-launched hepatitis C treatment surprise analysts
0
Allergan image
Valeant makes $45.7 billion Allergan offer
Canadian firm puts cards on table for Botox maker following rebuff from board
0
kadcyla image
NICE rejects Kadcyla
Watchdog criticises Roche’s pricing but firm and charity hit out at decision
>> More News Stories

Features

Working Life: GE Healthcare’s Emmanuel Ligner
Emmanuel image

The general manager, commercial EMEA of GE Healthcare Life Sciences talks to Pharmafile

>> More Features
>> More News Stories